Interpace Biosciences, Inc.

OTCPK:IDXG Voorraadrapport

Marktkapitalisatie: US$10.8m

Interpace Biosciences Beheer

Beheer criteriumcontroles 4/4

Interpace Biosciences' CEO is Tom Burnell, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is $678.41K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 1.86% of the company’s shares, worth $200.26K. The average tenure of the management team and the board of directors is 2.8 years and 4.8 years respectively.

Belangrijke informatie

Tom Burnell

Algemeen directeur

US$678.4k

Totale compensatie

Percentage CEO-salaris64.2%
Dienstverband CEO3.9yrs
Eigendom CEO1.9%
Management gemiddelde ambtstermijn2.8yrs
Gemiddelde ambtstermijn bestuur4.8yrs

Recente managementupdates

Recent updates

Interspace Biosciences trades high, appoints new finance chief

Feb 04

Interpace signs licensing agreement for monoclonal antibody platform Das-1

Feb 01

Analyse CEO-vergoeding

Hoe is Tom Burnell's beloning veranderd ten opzichte van Interpace Biosciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

US$3m

Mar 31 2024n/an/a

US$1m

Dec 31 2023US$678kUS$436k

US$1m

Sep 30 2023n/an/a

-US$1m

Jun 30 2023n/an/a

-US$2m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$634kUS$434k

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$588kUS$425k

-US$7m

Sep 30 2021n/an/a

-US$13m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$24m

Dec 31 2020US$935kUS$35k

-US$29m

Compensatie versus markt: Tom's total compensation ($USD678.41K) is about average for companies of similar size in the US market ($USD655.02K).

Compensatie versus inkomsten: Tom's compensation has been consistent with company performance over the past year.

CEO

Tom Burnell (62 yo)

3.9yrs

Tenure

US$678,407

Compensatie

Dr. Thomas W. Burnell, also known as Tom, Ph.D. serves as the President, Chief Executive Officer and Director at Interpace Biosciences, Inc. since December 01, 2020 and serves as its Chairman from February...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 200.3k
Christopher McCarthy
Chief Financial Officer1.6yrsUS$332.04k1.04%
$ 111.9k
Sydney Finkelstein
Chief Scientific Officerno datageen gegevensgeen gegevens
Jody Campbell
Chief Revenue Officer2.8yrsgeen gegevensgeen gegevens
Nicole Massoll
Chief Medical Officerless than a yeargeen gegevensgeen gegevens
Patrick Kane
VP & Corporate Controller15.4yrsgeen gegevensgeen gegevens

2.8yrs

Gemiddelde duur

Ervaren management: IDXG's management team is considered experienced (2.8 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Thomas Burnell
President3.9yrsUS$678.41k1.86%
$ 200.3k
Joseph Keegan
Independent Director8.8yrsUS$50.00k0.040%
$ 4.3k
Stephen Sullivan
Independent Director20.2yrsUS$62.50k0.056%
$ 6.0k
Vijay Aggarwal
Independent Director2.8yrsUS$50.00k0%
$ 0
Fortunato Rocca
Independent Director4.8yrsUS$40.00k0%
$ 0

4.8yrs

Gemiddelde duur

70yo

Gemiddelde leeftijd

Ervaren bestuur: IDXG's board of directors are considered experienced (4.8 years average tenure).